Drug industry
Article Abstract:
Drug company earnings in the 3rd qtr of 1995 are above, or in line with, industry expectations. Takeover speculation and sector rotation are both benefitting the industry. Further industry consolidation may inflate drug stock prices, but only three of 28 listed drug company stocks declined in the 3rd qtr of 1995. Investors need to closely monitor stocks on an individual basis before purchase of these shares.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Novartis AG
Article Abstract:
The shares of Novartis AG have decent price appreciation potential over the 2010-2012 timeframe. The Swiss company offers a variety of pharmaceutical and health care products such as vaccines and generics.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
User Contributions:
Comment about this article or add new information about this topic: